Problem
The SUS generates a large volume of data that is often dispersed in different systems, making it difficult to access, integrate, and analyze information. This fragmentation makes management more complex, increases the time spent searching and organizing data, and makes it difficult to make strategic decisions. The GIS seeks to address this problem, making information more organized, integrated, and accessible to support more efficient public health management.
Solution
SigAI proposes to solve this problem through an integrated management platform that centralizes, organizes, and crosses data from different SUS systems. The solution transforms dispersed data into clear and accessible information, presented through indicators and visualization panels. In this way, public managers will be able to monitor relevant information more quickly, identify needs and support strategic decision-making, contributing to more efficient and data-based public health management
Business model
The SIG business model will be B2G, based on SaaS (Software as a Service), through the licensing and subscription of the platform to municipalities, health departments and other public agencies. Revenue may include monthly fees for using the solution, in addition to deployment, integration, customization, training, and support services.
The average ticket is still being validated and will be defined according to the size of the municipality, volume of data, number of users, necessary integrations and level of customization of the solution. The proposal is to work with scalable plans, allowing services from small municipalities to larger public health management structures.
Market
GIS is part of the global health technology and data analysis market, a rapidly expanding sector driven by the digitalization of health systems, the increase in the volume of data, and the growing need for integration and interoperability between different platforms. Although the solution initially focuses on the SUS and the Brazilian market, the problem of fragmentation of health data is global, allowing the technology to be adapted to other public and private health systems in the future.
Competitors
Among the main competitors and alternative solutions are the SUS Digital Manager, e-SUS APS, SIAPS and other public platforms for managing and analyzing health data. The differential of GIS lies in its proposal to integrate information from different SUS systems into a single, simple and intelligent interface, facilitating visualization, analysis, and decision-making by public managers.
Competitive differentiation
SigAI's competitive advantage lies in its proposal to act as an intelligent and complementary layer to existing SUS systems, integrating information from different sources into a single environment. The platform seeks to offer a simple, flexible experience adapted to the needs of managers, transforming dispersed data into indicators and strategic information that are easy to interpret. Instead of replacing official systems, SigAI aims to enhance the use of existing data, reducing information fragmentation and facilitating more agile and data-based decision-making.
Entry barrier
The main barrier to entry to the GIS will be built on the basis of accumulated knowledge about the integration and standardization of different SUS data sources, combined with the adaptation of the platform to the real needs of public managers. As the solution is implemented in different municipalities, the GIS will be able to develop integration models, indicators, and processes that are increasingly efficient and personalized. This technical knowledge, combined with the history of implementations, partnerships and experience with the reality of public health management, creates an advantage that is difficult to be replicated quickly by new competitors.
Traction
SIGAI is currently in an early phase of development and validation. We have already developed a first functional prototype of the solution and are making progress in structuring and improving the platform. At this time, we still do not have commercial traction metrics, such as paying customers or recurring revenue, as our current focus is on validating the solution and preparing for the first tests and partnerships with public health managers.